COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 2216: Articles 22151-22160  | Next

On Modeling of COVID-19 for the Indian Subcontinent using Polynomial and Supervised Learning Regression
Neve, D., Patel, H., Dhiman, H. S.
10.1101/2020.10.14.20212563 — Posted: 2020-10-16
Title: COVID-19 and frontline health workers in West Africa: a scoping review
Pereko, K. K. A., Ameyaw, E. K., Bukari, S., Acquaye, V., Dai-Kosi, A. D.
10.1101/2020.10.15.20213249 — Posted: 2020-10-16
Understanding the value of clinical symptoms of COVID-19. A logistic regression model
Fleitas, P. E., Paz, J. A., Simoy, M. I., Vargas, C., Cimino, R. O., Krolewiecki, A. J., Aparicio, J. P.
10.1101/2020.10.07.20207019 — Posted: 2020-10-16
Analysis of Collective Response Reveals that COVID-19-Related Activities Start From the End of 2019 in Mainland China
Liu, J., Huang, T., Xiong, H., Huang, J., Zhou, J., Jiang, H., Yang, G., Wang, H., Dou, D.
10.1101/2020.10.14.20202531 — Posted: 2020-10-16
Novel Machine-Learned Approach for COVID-19 Resource Allocation: A Tool for EvaluatingCommunity Susceptibility
Kale, N.
10.1101/2020.10.14.20212571 — Posted: 2020-10-16
SARS-CoV-2 S protein ACE2 interaction reveals novel allosteric targets
Anand, G. S., Palur, R., Tulsian, N. K., Samsudin, F., Qian, X., Purushotorman, K., Yue, G., McQueen, M. K., Lescar, J., Bond, P., McAry, P. A.
10.1101/2020.10.13.337212 — Posted: 2020-10-16
sMAdCAM:IL-6 (sMIL Index): A novel signature associated with COVID-19 disease progression and development of anti-SARS-CoV-2 antibodies
Jagtap, D., Bhor, V. M., Bhowmick, S., Kasarpalkar, N., Sagvekar, P., Kulkarni, B., Pathak, M., Chatterjee, N., Dolas, P., Palav, H., Kaginkar, S., Bhagat, S., Munshi, I., Parikh, S., Agrawal, S., Pawar, C., Kaneria, M., Mahale, S., Shastri, J., Patel, V.
10.1101/2020.10.13.20182949 — Posted: 2020-10-16
Recovery of monocyte exhaustion is associated with resolution of lung injury in COVID-19 convalescence.
Scott, N. A., Knight, S. B., Pearmain, L., Brand, O., Morgan, D. J., Jagger, C., Khan, S., Hackney, P., Smith, L., Menon, M., Konkel, J., Shuwa, H. A., Franklin, M., Kaestele, V., Harbach, S., Brij, S., Ustianowski, A., Uriel, A., Lindergard, G., Diar Bakerly, N., Dark, P., Mathioudakis, A., Gray, K., Lord, G., Felton, T., Brightling, C., Ho, L.-P., NIHR Respiratory TRC, , CIRCO, , Piper Hanley, K., Simpson, A., Grainger, J. R., Hussell, T., Mann, E. R.
10.1101/2020.10.10.20207449 — Posted: 2020-10-16
TREATMENT PROFILES AND CLINICAL OUTCOMES OF COVID-19 PATIENTS AT PRIVATE HOSPITAL IN JAKARTA
Ramatillah, D. L., Isnaini, S.
10.1101/2020.10.14.20212449 — Posted: 2020-10-16
shinyCurves, a shiny web application to analyse multisource qPCR amplification data: a COVID 19 case study
Olaechea-Lazaro, S., Garcia-Santisteban, I., Pineda, J. R., Badiola, I., Alonso, S., Bilbao, J. R., Fernandez-Jimenez, N.
10.1101/2020.10.14.20212381 — Posted: 2020-10-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).